Avanos Medical, Inc. (NYSE: AVNS) reported Q4 EPS of $0.30, $0.07 better than the analyst estimate of $0.23. Revenue for the quarter came in at $170 million versus the consensus estimate of $166.32 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2019 EPS of $1.15-$1.35, versus the consensus of $1.33.

• Based on current trends, the company expects 2019 net sales including Game Ready, to increase 6 to 8 percent, on a constant currency basis, compared to 2018

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.